AT2 cell–derived IgA trapped by the extracellular matrix in silica-induced pulmonary fibrosis

Mengling Chen,Jing Wang,Mengqin Yuan,Min Long,Yuheng Sun,Sha Wang,Wei Luo,Yun Zhou,Wei Zhang,Wei Jiang,Jie Chao
DOI: https://doi.org/10.1016/j.intimp.2023.110545
IF: 5.714
2023-06-30
International Immunopharmacology
Abstract:Pulmonary fibrosis is an interstitial lung disease caused by various factors such as exposure to workplace environmental contaminants, drugs, or X-rays. Epithelial cells are among the driving factors of pulmonary fibrosis. Immunoglobulin A (IgA), traditionally thought to be secreted by B cells, is an important immune factor involved in respiratory mucosal immunity. In the current study, we found that lung epithelial cells are involved in IgA secretion, which, in turn, promotes pulmonary fibrosis. Spatial transcriptomics and single-cell sequencing suggest that Igha transcripts were highly expressed in the fibrotic lesion areas of lungs from silica-treated mice. Reconstruction of B-cell receptor (BCR) sequences revealed a new cluster of AT2-like epithelial cells with a shared BCR and high expression of genes related to IgA production. Furthermore, the secretion of IgA by AT2-like cells was trapped by the extracellular matrix and aggravated pulmonary fibrosis by activating fibroblasts. Targeted blockade of IgA secretion by pulmonary epithelial cells may be a potential strategy for treating pulmonary fibrosis.
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?